Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Virol ; 74(24): 11966-71, 2000 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11090198

RESUMEN

Previous data indicate that immune mechanisms may be involved in developing capillary leakage during Sin Nombre virus (SNV) infection. Therefore, we investigated production of tumor necrosis factor alpha (TNF-alpha) by human alveolar macrophages and human umbilical vein endothelial cells (HUVEC) after infection with SNV. In addition, we examined the effect of TNF-alpha on HUVEC monolayer leakage. Our results reveal that although TNF-alpha decreases accumulation of viral nucleoproteins, TNF-alpha levels do not change in SNV-infected cells. In addition, supernatants from SNV-infected human alveolar macrophages did not cause a significant increase in endothelial monolayer permeability.


Asunto(s)
Endotelio Vascular/efectos de los fármacos , Endotelio Vascular/virología , Infecciones por Hantavirus/tratamiento farmacológico , Orthohantavirus , Factor de Necrosis Tumoral alfa/farmacología , Factor de Necrosis Tumoral alfa/uso terapéutico , Animales , Permeabilidad de la Membrana Celular/efectos de los fármacos , Chlorocebus aethiops , Medios de Cultivo Condicionados/farmacología , Endotelio Vascular/metabolismo , Infecciones por Hantavirus/virología , Humanos , Macrófagos Alveolares/metabolismo , Macrófagos Alveolares/virología , Células Vero
2.
Blood ; 90(6): 2482-91, 1997 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-9310501

RESUMEN

Clinical experience and laboratory data suggest that human cytomegalovirus (HCMV) is present in peripheral blood of seropositive individuals in a latent or persistent state and can be transmitted via blood products and be reactivated in seropositive immunocompromised patients. The pathophysiology of HCMV latency and the nature of HCMV interaction with hematopoietic cells remains unknown. In this study, we investigated the infection of bone marrow (BM) progenitor cells and their progeny as a model of HCMV latency. A clinical isolate and the recombinant laboratory strain Towne/lox containing the Escherichia coli beta galactosidase (beta-gal) gene regulated by immediately early (IE) HCMV promoter were used to infect highly purified CD34+ cells. Although the infection of these cells with a clinical isolate was associated with an inhibition of proliferation by 59%, an expansion of progeny derived from these cells was possible. Polymerase chain reaction analysis and staining for beta-gal have shown that HCMV persisted in infected BM CD34+ cells and their progeny for up to 4 weeks. However, IE and late gene products (mRNA and protein) were detected only late in the course of infection and their expression correlated with terminal macrophage differentiation of the CD34+-derived progeny. Although early infection of CD34+ progenitor cells was not productive (as shown by the plaque assay), infectious virus could be recovered from the terminally differentiated cultures. BM progenitor cells may serve as a reservoir of the latent virus with limited transcription. Proliferation and monocytic maturation of infected progenitors may lead to the numerical expansion of HCMV-infected cells, which serve as a source of HCMV dissemination and reactivation.


Asunto(s)
Citomegalovirus/crecimiento & desarrollo , Células Madre Hematopoyéticas/virología , Antígenos CD34 , Antígenos Virales/metabolismo , Células de la Médula Ósea , Diferenciación Celular , División Celular , Células Cultivadas , ADN Viral/metabolismo , Regulación Viral de la Expresión Génica , Humanos , Macrófagos/virología , Monocitos/virología , ARN Viral/metabolismo , Proteínas Virales/genética , Proteínas Virales/metabolismo , Latencia del Virus
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA